These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 12703181

  • 1. [Digoxin dosing in the aged: new pharmacokinetic system versus Jellife and Koup methods].
    Cuena Boy R, Martín Montero Mdel P.
    Invest Clin; 2003 Mar; 44(1):31-9. PubMed ID: 12703181
    [Abstract] [Full Text] [Related]

  • 2. [Best result of digoxin dosing in the aged by taking into account that both the elimination as well as the volume of distribution of the drug decrease when the kidney function deteriorates].
    Cuena Boy R, Ortiz de Apodaca Ruiz MA, Maciá Martínez MA.
    An Med Interna; 2002 Jul; 19(7):331-5. PubMed ID: 12224140
    [Abstract] [Full Text] [Related]

  • 3. [Predictive capacity of 3 methods for estimating the maintenance dose of digoxin in elderly patients].
    Cuena Boy R, Maciá Martínez MA, López Reneo R, Martín Montero MP.
    Arch Cardiol Mex; 2001 Jul; 71(4):306-12. PubMed ID: 11806033
    [Abstract] [Full Text] [Related]

  • 4. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW, Charland SL, Shaw LM, Kobrin S, Goldfarb S, Stanek EJ, Spinler SA.
    Pharmacotherapy; 1997 Jul; 17(3):584-90. PubMed ID: 9165563
    [Abstract] [Full Text] [Related]

  • 5. Correlation coefficient versus prediction error in assessing the accuracy of digoxin dosing methods.
    Lalonde RL, Pao D.
    Clin Pharm; 1984 Jul; 3(2):178-83. PubMed ID: 6723224
    [Abstract] [Full Text] [Related]

  • 6. A method of determining the dose of digoxin for heart failure in the modern era.
    Bauman JL, DiDomenico RJ, Viana M, Fitch M.
    Arch Intern Med; 1984 Jul; 166(22):2539-45. PubMed ID: 17159022
    [Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetics of digoxin in Thai pediatric patients.
    Preechagoon Y, Somsaard P, Petcharattana S.
    J Med Assoc Thai; 2009 Oct; 92(10):1324-35. PubMed ID: 19845241
    [Abstract] [Full Text] [Related]

  • 8. Comparison of methods for estimating digoxin dosing regimens.
    Hyneck ML, Johnson MH, Wagner JG, Williams GW.
    Am J Hosp Pharm; 1981 Jan; 38(1):69-73. PubMed ID: 7211872
    [Abstract] [Full Text] [Related]

  • 9. [Digoxin plasma levels in four different prescription schedules of common use in clinical practice].
    Reinbach R, Villa L, Giraudo P, Venegas R, Fernández P.
    Rev Med Chil; 2003 Apr; 131(4):373-80. PubMed ID: 12870231
    [Abstract] [Full Text] [Related]

  • 10. Validation and application of a 96-well format solid-phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of digoxin in human plasma.
    Hashimoto Y, Shibakawa K, Nakade S, Miyata Y.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun 15; 869(1-2):126-32. PubMed ID: 18515196
    [Abstract] [Full Text] [Related]

  • 11. [Clinical study on digoxin tablets with high bioavailability (author's transl)].
    Flasch CI, Heinz N.
    Arzneimittelforschung; 1979 Jun 15; 29(6):961-4. PubMed ID: 582792
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment.
    Moffett BS, Cannon BC, Friedman RA, Kertesz NJ.
    Pharmacotherapy; 2006 Dec 15; 26(12):1687-93. PubMed ID: 17125432
    [Abstract] [Full Text] [Related]

  • 13. [What value do body weight, age and drug anamnesis have as an index of elevated digoxin level?].
    Bachmayer K, Wytek R.
    Wien Klin Wochenschr; 1986 Mar 21; 98(6):165-70. PubMed ID: 3705594
    [Abstract] [Full Text] [Related]

  • 14. Effect of exenatide on the steady-state pharmacokinetics of digoxin.
    Kothare PA, Soon DK, Linnebjerg H, Park S, Chan C, Yeo A, Lim M, Mace KF, Wise SD.
    J Clin Pharmacol; 2005 Sep 21; 45(9):1032-7. PubMed ID: 16100297
    [Abstract] [Full Text] [Related]

  • 15. The serum digoxin concentration: ten questions to ask.
    Cauffield JS, Gums JG, Grauer K.
    Am Fam Physician; 1997 Aug 21; 56(2):495-503, 509-10. PubMed ID: 9262530
    [Abstract] [Full Text] [Related]

  • 16. Effect of lasofoxifene on the pharmacokinetics of digoxin in healthy postmenopausal women.
    Roman D, Bramson C, Ouellet D, Randinitis E, Gardner M.
    J Clin Pharmacol; 2005 Dec 21; 45(12):1407-12. PubMed ID: 16291716
    [Abstract] [Full Text] [Related]

  • 17. [Pharmacokinetics of digoxin in the aged].
    van der Aa GC.
    Tijdschr Gerontol Geriatr; 1984 Apr 21; 15(2):67-71. PubMed ID: 6719536
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
    Mao ZL, Stalker D, Keirns J.
    Clin Ther; 2009 Jul 21; 31(7):1542-50. PubMed ID: 19695403
    [Abstract] [Full Text] [Related]

  • 19. [Serum digoxin concentration: dependence on body weight and age].
    Kaufmann G, Neumann P.
    Schweiz Med Wochenschr; 1977 Nov 26; 107(47):1695-9. PubMed ID: 929130
    [Abstract] [Full Text] [Related]

  • 20. A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
    Schmitt A, Gladieff L, Lansiaux A, Bobin-Dubigeon C, Etienne-Grimaldi MC, Boisdron-Celle M, Serre-Debauvais F, Pinguet F, Floquet A, Billaud E, Le Guellec C, Penel N, Campone M, Largillier R, Capitain O, Fabbro M, Houede N, Medioni J, Bougnoux P, Lochon I, Chatelut E.
    Clin Cancer Res; 2009 May 15; 15(10):3633-9. PubMed ID: 19401344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.